Every 10-Q that Corvel Corp (CRVL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CRVL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRVL filings page.
CorVel Corporation reported higher managed care results for the quarter ended June 30, 2026, with revenue of $259.9 million, up 10.7% year over year. Net income rose to $32.2 million, and diluted earnings per share increased to $0.63 from $0.52.
Gross margin improved to 26.1% as both patient management revenue ($159.3 million) and network solutions revenue ($100.6 million) grew, aided by more claims and enhanced bill review activity. Operating cash flow was $49.9 million, and cash and equivalents reached $255.9 million.
The company repurchased 377,098 shares for approximately $21.8 million, leaving 50.6 million shares outstanding at June 30, 2026. Leadership changed on July 1, 2026, as Sarah A. Scott became Chief Executive Officer and President, with former CEO Michael G. Combs transitioning to Executive Chair. Management highlights competition, inflationary pressures, and technology disruption as key ongoing risks.
CorVel Corporation reported modest growth for the quarter ended December 31, 2025. Revenue rose to $235.6 million from $228.0 million, driven mainly by stronger network solutions activity with existing customers. Quarterly net income increased slightly to $24.2 million, with diluted earnings per share up to $0.47.
For the first nine months of the fiscal year, revenue grew to $710.0 million, up 6.9%, while net income climbed 15.4% to $79.3 million. Gross margin improved to 23.9% and operating cash flow reached $126.2 million, allowing continued investment in software and ongoing share repurchases.
CorVel Corporation reported stronger quarterly results for the three months ended September 30, 2025. Revenue reached $239,643,000, up 7% year over year, as network solutions activity expanded with existing customers. Net income was $27,906,000 and diluted EPS was $0.54, compared with $0.45 a year ago.
Profitability improved: gross margin rose to 24.3% from 22.6%, while general and administrative costs held near 9% of revenue. Segment mix was 62.9% patient management ($150,795,000) and 37.1% network solutions ($88,848,000). Operating cash flow for the first six months totaled $80,035,000, supporting cash and equivalents of $207,453,000.
The company continued buybacks, repurchasing 143,774 shares for approximately $12.8 million in the quarter and 230,879 shares for $22.5 million year-to-date. Shares outstanding were 51,293,374 as of September 30, 2025. Management also noted a recent technology asset acquisition to enhance bill review capabilities.